[go: up one dir, main page]

PL376638A1 - Estry kwasu karbaminowego o działaniu antycholinergicznym - Google Patents

Estry kwasu karbaminowego o działaniu antycholinergicznym

Info

Publication number
PL376638A1
PL376638A1 PL376638A PL37663803A PL376638A1 PL 376638 A1 PL376638 A1 PL 376638A1 PL 376638 A PL376638 A PL 376638A PL 37663803 A PL37663803 A PL 37663803A PL 376638 A1 PL376638 A1 PL 376638A1
Authority
PL
Poland
Prior art keywords
carbamic acid
acid esters
anticholinergic action
anticholinergic
action
Prior art date
Application number
PL376638A
Other languages
English (en)
Inventor
Matthias Grauert
Michael P. Pieper
Steffen Breitfelder
Matthias Hoffmann
Georg Speck
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of PL376638A1 publication Critical patent/PL376638A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL376638A 2002-11-26 2003-11-19 Estry kwasu karbaminowego o działaniu antycholinergicznym PL376638A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10255040A DE10255040A1 (de) 2002-11-26 2002-11-26 Neue Carbaminsäureester mit anticholinerger Wirksamkeit

Publications (1)

Publication Number Publication Date
PL376638A1 true PL376638A1 (pl) 2006-01-09

Family

ID=32240420

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376638A PL376638A1 (pl) 2002-11-26 2003-11-19 Estry kwasu karbaminowego o działaniu antycholinergicznym

Country Status (20)

Country Link
EP (1) EP1567526B1 (pl)
JP (1) JP4754829B2 (pl)
KR (1) KR20050086821A (pl)
CN (1) CN1717408A (pl)
AT (1) ATE392424T1 (pl)
AU (1) AU2003289880A1 (pl)
BR (1) BR0316549A (pl)
CA (1) CA2507110C (pl)
DE (2) DE10255040A1 (pl)
EA (1) EA200500775A1 (pl)
EC (1) ECSP055803A (pl)
ES (1) ES2304538T3 (pl)
HR (1) HRP20050465A2 (pl)
MX (1) MXPA05005443A (pl)
NO (1) NO20053089L (pl)
PL (1) PL376638A1 (pl)
RS (1) RS20050384A (pl)
UA (1) UA81649C2 (pl)
WO (1) WO2004048373A1 (pl)
ZA (1) ZA200502946B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE435862T1 (de) 2003-05-28 2009-07-15 Theravance Inc Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
TW200534855A (en) * 2004-01-13 2005-11-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
JP2008505118A (ja) * 2004-06-30 2008-02-21 グラクソ　グループ　リミテッド ムスカリン性アセチルコリン受容体アンタゴニスト
JP2008520573A (ja) * 2004-11-15 2008-06-19 グラクソ グループ リミテッド 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
WO2007007282A2 (en) * 2005-07-11 2007-01-18 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
US20090182033A1 (en) * 2005-12-16 2009-07-16 Argenta Discovery Ltd. Cyclic Amine Derivatives and Their Uses
US8367696B2 (en) 2007-02-09 2013-02-05 Astellas Pharma Inc. Aza-bridged-ring compound
PT3691620T (pt) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019096226A1 (en) 2017-11-16 2019-05-23 Chengdu Easton Biopharmaceuticals Co., Ltd. Pasylated vegfr/pdgfr fusion proteins and their use in therapy
JP2021505569A (ja) * 2017-12-04 2021-02-18 フリードリヒ−アレクサンダー−ウニヴェルシテート エアランゲン−ニュルンベルク Ｍ２よりもｍ３に対して選択性を有するフルオロフェニル置換ムスカリン受容体リガンド
KR20220001259A (ko) 2020-06-29 2022-01-05 (주)아모레퍼시픽 표면처리된 무기입자, 이의 제조방법, 이의 분산액 및 이를 포함하는 화장료 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759460A (fr) * 1969-11-26 1971-05-26 Knoll Ag Nouveaux carbamates et leur procede de preparation
GB8600978D0 (en) * 1986-01-16 1986-02-19 Beecham Group Plc Compounds
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
EP0747355A4 (en) * 1994-02-10 1997-04-09 Yamanouchi Pharma Co Ltd NEW CARBAMATES AND MEDICINAL PRODUCTS CONTAINING THEM
AU724780B2 (en) * 1996-03-20 2000-09-28 Wake Forest University Sigma-2 receptors as biomarkers of tumor cell proliferation

Also Published As

Publication number Publication date
JP2006514010A (ja) 2006-04-27
CA2507110C (en) 2012-07-10
DE50309655D1 (de) 2008-05-29
BR0316549A (pt) 2005-10-04
JP4754829B2 (ja) 2011-08-24
DE10255040A1 (de) 2004-06-03
ES2304538T3 (es) 2008-10-16
ECSP055803A (es) 2005-08-11
NO20053089D0 (no) 2005-06-23
CN1717408A (zh) 2006-01-04
HRP20050465A2 (en) 2006-10-31
KR20050086821A (ko) 2005-08-30
AU2003289880A1 (en) 2004-06-18
EA200500775A1 (ru) 2005-12-29
RS20050384A (sr) 2007-12-31
CA2507110A1 (en) 2004-06-10
WO2004048373A1 (de) 2004-06-10
NO20053089L (no) 2005-06-23
EP1567526B1 (de) 2008-04-16
UA81649C2 (ru) 2008-01-25
EP1567526A1 (de) 2005-08-31
MXPA05005443A (es) 2005-08-03
ZA200502946B (en) 2005-11-23
ATE392424T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
DE602004008895D1 (en) Dpp-iv-hemmer
SG149061A1 (en) Definitive endoderm
CA2425560A1 (en) Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
ATE335738T1 (de) Xanthencarbonsäureester des tropenols und scopins als m3-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
PL376638A1 (pl) Estry kwasu karbaminowego o działaniu antycholinergicznym
TNSN06451A1 (en) Radiation curable composition consisting of unsaturated amorphous polyesters and reactive dilutant agents
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
CA2421990A1 (en) .beta.-thioamino acids
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
MXPA02012112A (es) Composiciones que contienen policarbonato.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
WO2004024681A3 (fr) NOUVEAUX COMPOSES COMPRENANT UN GROUPEMENT THIOCARBONYLSULFANYLE UTILES POUR LA SYNTHESE DE COMPOSES α-PERFLUOROALKYLAMINES PAR VOIE RADICALAIRE
MXPA05006938A (es) Proceso para producir derivados de bencilamina.
WO2004052831A3 (de) Verfahren zur herstellung optisch aktiver dihydropyrone
ATE399779T1 (de) Zwischenprodukte für die herstellung von neuraminidase-inhibitor-konjugaten
WO2004096829A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes-17-halogenes
TW200700380A (en) Polyfunctional (meth)acrylic acid ester composition and method for producing the same
WO2001051457A3 (de) Verfahren zur herstellung von aryl-iminomethyl-carbaminsäureestern
MXPA05008862A (es) Heterociclos de nitrogeno n-arilo sustituidos.
AU2003299334A1 (en) Esters of allyl substituted by a difluoromethylene group, method for the synthesis thereof and use thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)